Magenta Medical Completes Enrollment to Early Feasibility St

The developer of the Elevate heart pump system, Magenta Medical, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.

Related Keywords

France , Israel , New York , United States , Israeli , French , Rajiv Jauhar , Samin Sharma , Perwaizm Meraj , Heart Center , Mount Sinai Health System , Shore University Hospital Northwell Health System , Shore University Hospital , Magenta Medical Ltd , Catheterization Laboratory , Magenta Medical , Breakthrough Device , Early Feasibility Study , Mount Sinai Hospital , Francis Hospital , North Shore University , Elevate Early Feasibility Study , Elevate System , Interventional Cardiology , New York City , Device Designation , Cardiac Catheterization Laboratory , North Shore University Hospital , Northwell Health System , David Israeli , Breakthrough Device Designation ,